Showing results (211-220 of 255) with videos related to

Sort By:
Pageof 26
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosisKristen A Rahn, Crystal C Watkins, Jesse Alt, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 27, 2025
Inhibition of microglial glutaminase alleviates chronic stress-induced neurobehavioral and cognitive deficitsMeixiang Huang, Yannan Li, Ajit G Thomas, et al.
Pharmaceutics|October 27, 2022
Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in MiceCarolyn Tallon, Benjamin J Bell, Anjali Sharma, et al.
Biorxiv : the Preprint Server for Biology|March 26, 2024
Development of novel tools for dissection of central versus peripheral dopamine D2-like receptor signaling in dysglycemiaAlessandro Bonifazi, Michael Ellenberger, Zachary J Farino, et al.
Diabetes|June 13, 2024
Development of Novel Tools for Dissection of Central Versus Peripheral Dopamine D2-Like Receptor Signaling in DysglycemiaAlessandro Bonifazi, Michael Ellenberger, Zachary J Farino, et al.
Molecular Cancer Therapeutics|October 10, 2019
The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath TumorKathryn M Lemberg, Liang Zhao, Ying Wu, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
BCG vaccination mitigates tau pathology and restores cognitive function in PS19 miceSomnath Shee, Meixiang Huang, Meghraj Singh Baghel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 14, 2019
Correction: JHU-083 selectively blocks glutaminase activity in brain CD11b+ cells and prevents depression-associated behaviors induced by chronic social defeat stressXiaolei Zhu, Michael T Nedelcovych, Ajit G Thomas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 22, 2018
JHU-083 selectively blocks glutaminase activity in brain CD11b+ cells and prevents depression-associated behaviors induced by chronic social defeat stressXiaolei Zhu, Michael T Nedelcovych, Ajit G Thomas, et al.
Molecular Cancer Therapeutics|August 24, 2023
Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath TumorKathryn M Lemberg, Eunus S Ali, Marcela Krecmerova, et al.
Pageof 26